Boston Scientific (BSX) Other Non Operating Income (2009 - 2026)

Boston Scientific has disclosed Other Non Operating Income across 18 years of filings, most recently posting $151.0 million for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $151.0 million, up 230.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $216.0 million (up 140.0% YoY), and the FY2025 annual result was -$228.0 million, down 1325.0% from the prior year.
• Other Non Operating Income came in at $151.0 million for Q1 2026 at Boston Scientific, up from -$125.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $215.0 million in Q4 2024 to a low of -$412.0 million in Q4 2022.
• The 5-year median for Other Non Operating Income is -$23.0 million (2024), against an average of -$21.4 million.
• Across the five-year window, Other Non Operating Income tumbled 1684.62% in 2022 and jumped 1533.33% in 2024, its largest moves.
• Boston Scientific's Other Non Operating Income stood at -$412.0 million in 2022, then soared by 96.36% to -$15.0 million in 2023, then jumped by 1533.33% to $215.0 million in 2024, then tumbled by 158.14% to -$125.0 million in 2025, then jumped by 220.8% to $151.0 million in 2026.
• The last three Other Non Operating Income figures came in at $151.0 million (Q1 2026), -$125.0 million (Q4 2025), and -$23.0 million (Q3 2025), per Business Quant data.